Setting and Implementing Standards for Narrow Therapeutic Index Drugs

CDER's Narrow Therapeutic Index Drugs (NTI) working group works to resolve key NTI scientific and regulatory issues.

Source: FDA Center for Drug Evaluation and Research - What's New - February 26, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news